Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/29716
Title: Perspectives for cancer immunotherapy mediated by p19Arf plus interferon-beta gene transfer
Authors: STRAUSS, Bryan E.SILVA, Gissele Rolemberg OliveiraVIEIRA, Igor de LunaCERQUEIRA, Otto Luiz DutraVALLE, Paulo Roberto DelMEDRANO, Ruan Felipe VieiraMENDONCA, Samir Andrade
Citation: CLINICS, v.73, suppl.1, article ID UNSP e479s, 11p, 2018
Abstract: While cancer immunotherapy has gained much deserved attention in recent years, many areas regarding the optimization of such modalities remain unexplored, including the development of novel approaches and the strategic combination of therapies that target multiple aspects of the cancer-immunity cycle. Our own work involves the use of gene transfer technology to promote cell death and immune stimulation. Such immunogenic cell death, mediated by the combined transfer of the alternate reading frame (p14ARF in humans and p19Arf in mice) and the interferon-beta cDNA in our case, was shown to promote an antitumor immune response in mouse models of melanoma and lung carcinoma. With these encouraging results, we are now setting out on the road toward translational and preclinical development of our novel immunotherapeutic approach. Here, we outline the perspectives and challenges that we face, including the use of human tumor and immune cells to verify the response seen in mouse models and the incorporation of clinically relevant models, such as patient-derived xenografts and spontaneous tumors in animals. In addition, we seek to combine our immunotherapeutic approach with other treatments, such as chemotherapy or checkpoint blockade, with the goal of reducing dosage and increasing efficacy. The success of any translational research requires the cooperation of a multidisciplinary team of professionals involved in laboratory and clinical research, a relationship that is fostered at the Cancer Institute of Sao Paulo.
Appears in Collections:

Artigos e Materiais de Revistas Científicas - HC/ICESP
Instituto do Câncer do Estado de São Paulo - HC/ICESP

Artigos e Materiais de Revistas Científicas - LIM/24
LIM/24 - Laboratório de Oncologia Experimental

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_STRAUSS_Perspectives_for_cancer_immunotherapy_mediated_by_p19Arf_plus_2018.PDFpublishedVersion (English)643.24 kBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.